| Dr Blake Norton Geren, MD | |
|
7901 Dallas St, Fort Smith, AR 72903-4281 | |
| (479) 782-8892 | |
| (479) 782-8840 |
| Full Name | Dr Blake Norton Geren |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 21 Years |
| Location | 7901 Dallas St, Fort Smith, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063448405 | NPI | - | NPPES |
| CQ2484 | Other | RAILROAD MEDICARE | |
| 200115630A | Medicaid | OK | |
| P00419389 | Other | AR | RAILROAD MEDICARE |
| 164798001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | E5157 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Group, Llc | 8921066697 | 3 |
News Archive
In a major step toward commercialization of a promising therapeutic treatment, Oak Ridge National Laboratory contractor UT-Battelle announced at a signing ceremony here today that it has exclusively licensed patents on inventions based on the Nell-1 gene to NellOne Therapeutics, Inc. (NellOne), a company spun out of research performed at the Department of Energy laboratory.
Fuyuhiko Tamanoi of Kyoto University's Institute for Integrated Cell-Material Sciences and colleagues in the US succeeded in establishing a versatile, powerful and convenient model to analyze human cancer.
New research, published in Neuron, gives insight into how single mutations in the VCP gene cause a range of neurological conditions including a form of dementia called Inclusion Body Myopathy, Paget's Disease of the Bone and Frontotemporal Dementia (IBMPFD), and the motor neuron disease Amyotrophic Lateral Sclerosis (ALS).
Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced that Takeda has entered into a co-promotion agreement with Janssen Pharmaceutical K.K. for VELCADE® (bortezomib) for Injection, a treatment for patients with multiple myeloma.
› Verified 2 days ago
| Entity Name | Eye Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366414187 PECOS PAC ID: 8921066697 Enrollment ID: O20041228000494 |
News Archive
In a major step toward commercialization of a promising therapeutic treatment, Oak Ridge National Laboratory contractor UT-Battelle announced at a signing ceremony here today that it has exclusively licensed patents on inventions based on the Nell-1 gene to NellOne Therapeutics, Inc. (NellOne), a company spun out of research performed at the Department of Energy laboratory.
Fuyuhiko Tamanoi of Kyoto University's Institute for Integrated Cell-Material Sciences and colleagues in the US succeeded in establishing a versatile, powerful and convenient model to analyze human cancer.
New research, published in Neuron, gives insight into how single mutations in the VCP gene cause a range of neurological conditions including a form of dementia called Inclusion Body Myopathy, Paget's Disease of the Bone and Frontotemporal Dementia (IBMPFD), and the motor neuron disease Amyotrophic Lateral Sclerosis (ALS).
Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced that Takeda has entered into a co-promotion agreement with Janssen Pharmaceutical K.K. for VELCADE® (bortezomib) for Injection, a treatment for patients with multiple myeloma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Blake Norton Geren, MD 7901 Dallas St, Fort Smith, AR 72903-4281 Ph: (479) 782-8892 | Dr Blake Norton Geren, MD 7901 Dallas St, Fort Smith, AR 72903-4281 Ph: (479) 782-8892 |
News Archive
In a major step toward commercialization of a promising therapeutic treatment, Oak Ridge National Laboratory contractor UT-Battelle announced at a signing ceremony here today that it has exclusively licensed patents on inventions based on the Nell-1 gene to NellOne Therapeutics, Inc. (NellOne), a company spun out of research performed at the Department of Energy laboratory.
Fuyuhiko Tamanoi of Kyoto University's Institute for Integrated Cell-Material Sciences and colleagues in the US succeeded in establishing a versatile, powerful and convenient model to analyze human cancer.
New research, published in Neuron, gives insight into how single mutations in the VCP gene cause a range of neurological conditions including a form of dementia called Inclusion Body Myopathy, Paget's Disease of the Bone and Frontotemporal Dementia (IBMPFD), and the motor neuron disease Amyotrophic Lateral Sclerosis (ALS).
Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced that Takeda has entered into a co-promotion agreement with Janssen Pharmaceutical K.K. for VELCADE® (bortezomib) for Injection, a treatment for patients with multiple myeloma.
› Verified 2 days ago
Dr. Randy M Ennen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3312 S 70th St, Fort Smith, AR 72903 Phone: 479-452-7800 Fax: 479-452-9486 | |
Dr. Robert Paul Hughes Jr., M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 115 N 10th St Ste H, Fort Smith, AR 72901 Phone: 479-790-7000 | |
Dr. Christopher A Greer, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-4400 Fax: 479-274-4499 | |
Dr. Robert B Knox, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7901 Dallas St, Fort Smith, AR 72903 Phone: 479-782-8892 Fax: 479-782-8840 | |
Chetan Rasiklal Soni, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave Fl 5, Fort Smith, AR 72903 Phone: 479-274-4400 Fax: 479-274-4499 | |
Dr. Claire B Price, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7901 Dallas St, Fort Smith, AR 72903 Phone: 479-782-8892 Fax: 479-782-8840 |